Health and economic burden of hpv-related diseases in singapore

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 1, 2012, Pages 305-308

  Low, Jeffrey Jen Hui ^a   Ko, Yu ^b   Ilancheran, Arunachalam ^a   Zhang, Xu Hao ^c   Singhal, Puneet K ^d   Tay, Sun Kuie ^e  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c Medical Department   (Singapore)

^d MERCK RESEARCH LABORATORIES   (United States)

^e SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Cost of illness; Human papillomavirus; Singapore

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CONDYLOMA ACUMINATUM; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; HEALTH CARE DELIVERY; HUMAN; INCIDENCE; INFANT; ISOLATION AND PURIFICATION; MIDDLE AGED; NEWBORN; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PRESCHOOL CHILD; PROGNOSIS; SINGAPORE; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VIROLOGY;

ADOLESCENT; ADULT; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHILD; CHILD, PRESCHOOL; CONDYLOMATA ACUMINATA; COST-BENEFIT ANALYSIS; DELIVERY OF HEALTH CARE; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; SINGAPORE; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84864885018     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.1.305     Document Type: Article

References (19)

1. Annemans L, Remy V, Lamure E, et al (2008). Economic burden associated with the management of cervical cancer, cervical dysplasia and genital warts in Belgium. J Med Econ, 11, 135-50.
2. Chaturvedi AK (2010). Beyond cervical cancer: burden of other HPV-related cancers among men and women. J Adolesc Health, 46, S20-6.
3. Dillner J, Kjaer SK, Wheeler CM, et al (2010). Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. BMJ, 341, c3493.
4. Ebrahim SH, McKenna MT, Marks JS (2005). Sexual behaviour: related adverse health burden in the United States. Sex Transm Infect, 81, 38-40.
5. Insinga RP (2006). Annual productivity costs due to cervical cancer mortality in the United States. Womens Health Issues, 16, 236-42.
6. Insinga RP, Dasbach EJ, Elbasha EH (2005). Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature. Pharmacoeconomics, 23, 1107-22.
7. Koutsky LA, Harper DM (2006). Chapter 13: Current findings from prophylactic HPV vaccine trials. Vaccine, 24, S3/114- 21.
8. Kulasingam SL, Hughes JP, Kiviat NB, et al (2002). Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA, 288, 1749-57.
9. Lipsy RJ (2008). Assessing the short-term and long-term burden of illness in cervical cancer. Am J Manag Care, 14, S177-84.
10. Max W, Rice DP, Sung HY, et al (2003). The economic burden of gynecologic cancers in California, 1998. Gynecol Oncol, 88, 96-103.
11. Ministry of Health, Singapore (2009). Communicable diseases surveillance in Singapore 2008.
12. National Health Insurance Research Database (2009). Disease Burden of Genital Wart in Taiwan.
13. National Skin Center (2006). Sexually Transmitted Infections Notification Report.
14. Paavonen J, Naud P, Salmeron J, et al (2009). Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet, 374, 301-14.
15. Parkin DM, Bray F (2006). Chapter 2: The burden of HPVrelated cancers. Vaccine, S3, 11-25.
16. Singapore Cancer Registry (2004). Trends in cancer incidence in Singapore 1968-2002 (Singapore,), pp. xi, 181 , 181 map 129 cm. + 181 CD-ROM (184 183/184 in.)
17. Walboomers JM, Jacobs MV, Manos MM, et al (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189, 12-9.
18. Wiley D, Masongsong E (2006). Human papillomavirus: the burden of infection. Obstet Gynecol Surv 61, S3-14.
19. Wong WK (2008). Population Trends 2008 (Singapore Department of Statistics).